We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$184M
AUM Growth
+$7.78M
Cap. Flow
+$55K
Cap. Flow %
0.03%
Top 10 Hldgs %
22.89%
Holding
99
New
4
Increased
25
Reduced
35
Closed
3

Sector Composition

Rank Sector Weight
1 Industrials 17.31%
2 Technology 13.13%
3 Financials 12.23%
4 Healthcare 10.54%
5 Consumer Staples 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRW icon
26
C.H. Robinson
CHRW
$20.6B
$3.17M 1.73%
41,041
-550
-1% -$42.3K
XYL icon
27
Xylem
XYL
$28.6B
$3.16M 1.72%
62,982
-2,750
-4% -$134K
UPS icon
28
United Parcel Service
UPS
$96B
$3.07M 1.67%
28,616
+230
+0.8% +$25.1K
IVV icon
29
iShares Core S&P 500 ETF
IVV
$869B
$3.01M 1.64%
12,702
+1,095
+9% +$256K
MDT icon
30
Medtronic
MDT
$108B
$3.01M 1.64%
37,350
+2,030
+6% +$159K
PG icon
31
Procter & Gamble
PG
$346B
$2.95M 1.61%
32,852
-30
-0.1% -$2.66K
WU icon
32
Western Union
WU
$2.55B
$2.95M 1.61%
144,845
-1,750
-1% -$35.7K
BNY
33
Bank of New York Mellon
BNY
$107B
$2.78M 1.51%
58,800
-1,770
-3% -$82.8K
GOOGL icon
34
Alphabet (Google) Class A
GOOGL
$3.99T
$2.75M 1.5%
64,840
-400
-0.6% -$16.8K
OMC icon
35
Omnicom Group
OMC
$23.5B
$2.73M 1.49%
31,679
-205
-0.6% -$17.5K
CVS icon
36
CVS Health
CVS
$137B
$2.72M 1.48%
34,667
+3,290
+10% +$263K
COP icon
37
ConocoPhillips
COP
$141B
$2.71M 1.48%
54,311
+200
+0.4% +$9.66K
IEFA icon
38
iShares Core MSCI EAFE ETF
IEFA
$188B
$2.71M 1.47%
46,720
+2,459
+6% +$138K
ABT icon
39
Abbott
ABT
$182B
$2.7M 1.47%
60,812
+4,140
+7% +$179K
STT icon
40
State Street
STT
$50.7B
$2.7M 1.47%
33,891
-355
-1% -$28.2K
BBH icon
41
VanEck Biotech ETF
BBH
$399M
$2.61M 1.42%
21,908
+935
+4% +$109K
SPY icon
42
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$2.48M 1.35%
10,509
-25
-0.2% -$5.81K
USB icon
43
US Bancorp
USB
$98.9B
$2.22M 1.21%
43,190
+145
+0.3% +$7.73K
PX
44
DELISTED
Praxair Inc
PX
$2.03M 1.11%
17,120
+555
+3% +$65.3K
VZ icon
45
Verizon
VZ
$198B
$2.02M 1.1%
41,529
+1,935
+5% +$97.1K
HYG icon
46
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2M 1.09%
22,825
+125
+0.6% +$10.9K
HWM icon
47
Howmet Aerospace
HWM
$115B
$1.88M 1.03%
93,300
+3,859
+4% +$75.8K
VB icon
48
Vanguard Small-Cap ETF
VB
$79.9B
$1.87M 1.02%
14,010
-530
-4% -$70.1K
OIH icon
49
VanEck Oil Services ETF
OIH
$2.06B
$1.68M 0.92%
2,732
-13
-0.5% -$8.45K
T icon
50
AT&T
T
$167B
$1.66M 0.91%
53,039

Similar funds

Boston Research & Management's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Research & Management held 99 positions worth $184M, up 4.4% from $176M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Boston Research & Management's Q1 2017 filing shows 4 new, 25 increased, 35 reduced and 3 closed positions. Its largest new stake was Mandiant, Inc. Common Stock: 18,900 shares worth $238K. The largest sale was Alcoa, an estimated $695K.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Research & Management's largest Q1 2017 buy was Mandiant, Inc. Common Stock: 18,900 shares worth $238K.
  • Boston Research & Management added most to Colgate-Palmolive in Q1 2017, an estimated $534K increase.
  • Boston Research & Management's biggest Q1 2017 reduction was Apple, cutting an estimated $242K.
  • Boston Research & Management fully exited Alcoa in Q1 2017, selling an estimated $695K.
  • Boston Research & Management's ten largest holdings make up 23% of its $184M portfolio in Q1 2017.
  • Boston Research & Management opened 4 new positions and closed 3 in Q1 2017.
  • Boston Research & Management's portfolio value rose 4.4% quarter-over-quarter to $184M.

Based on Boston Research & Management's 13F filing for Q1 2017, filed 5 May 2017.